{
    "ticker": "DXYN",
    "name": "Daxor Corporation",
    "description": "Daxor Corporation is a medical instrumentation and biotechnology company, primarily focused on developing and commercializing innovative blood volume measurement technology. Founded in 1983, the company specializes in the development of its flagship product, the BVA-100, which is designed to provide rapid and accurate assessments of a patient's blood volume status. This technology is particularly valuable in critical care and cardiology, where understanding blood volume is crucial for diagnosing and treating various conditions such as heart failure and fluid overload. Daxor's mission is to improve patient outcomes through precise diagnostic tools that enhance clinical decision-making. In addition to the BVA-100, the company is actively engaged in research and development to expand its product offerings and improve the efficiency of medical care. Daxor is committed to advancing medical science and providing healthcare professionals with the tools they need to enhance patient care. With a strong focus on innovation and quality, Daxor continues to make significant strides in the healthcare industry, aiming to become a leader in blood volume measurement and related diagnostic technologies.",
    "industry": [
        "Medical Devices",
        "Biotechnology"
    ],
    "headquarters": "New York, New York, USA",
    "founded": "1983",
    "website": "http://www.daxor.com",
    "ceo": "Dr. R. M. H. Dyer",
    "social_media": {
        "twitter": "https://twitter.com/DaxorCorp",
        "linkedin": "https://www.linkedin.com/company/daxor-corporation"
    },
    "investor_relations": "http://www.daxor.com/investor-relations",
    "key_executives": [
        {
            "name": "Dr. R. M. H. Dyer",
            "position": "CEO"
        },
        {
            "name": "Robert S. Karp",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Diagnostic Equipment",
            "products": [
                "BVA-100"
            ]
        }
    ],
    "seo": {
        "meta_title": "Daxor Corporation | Innovative Blood Volume Measurement Technology",
        "meta_description": "Daxor Corporation specializes in advanced diagnostic technology for blood volume measurement, improving patient care in critical settings. Learn more about Daxor's innovative products.",
        "keywords": [
            "Daxor",
            "Blood Volume Measurement",
            "Medical Devices",
            "Biotechnology",
            "BVA-100"
        ]
    },
    "faq": [
        {
            "question": "What is Daxor known for?",
            "answer": "Daxor is known for its innovative blood volume measurement technology, particularly the BVA-100 diagnostic device."
        },
        {
            "question": "Who is the CEO of Daxor?",
            "answer": "Dr. R. M. H. Dyer is the CEO of Daxor Corporation."
        },
        {
            "question": "Where is Daxor headquartered?",
            "answer": "Daxor is headquartered in New York, New York, USA."
        },
        {
            "question": "What products does Daxor offer?",
            "answer": "Daxor's main product is the BVA-100, a device for measuring blood volume."
        },
        {
            "question": "When was Daxor founded?",
            "answer": "Daxor was founded in 1983."
        }
    ],
    "competitors": [
        "ABT",
        "MDT",
        "HOLX"
    ],
    "related_stocks": [
        "UNH",
        "JNJ",
        "PFE",
        "MRK"
    ]
}